Compugen Ltd. (CGEN)
1.98
+0.01
(+0.51%)
USD |
NASDAQ |
Jan 14, 16:00
1.97
-0.01
(-0.51%)
After-Hours: 20:00
Compugen EPS Diluted (Quarterly): -0.0746 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Teva Pharmaceutical Industries Ltd. | 0.3737 |
| Kamada Ltd. | 0.0918 |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | -5.546 |
| Nasus Pharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.979M |
| Revenue (Quarterly) | 1.891M |
| Total Expenses (Quarterly) | 8.87M |
| Enterprise Value | 102.06M |
| Gross Profit Margin (Quarterly) | 12.74% |
| Profit Margin (Quarterly) | -369.1% |
| Earnings Yield | -15.11% |
| Normalized Earnings Yield | -15.11 |